全文获取类型
收费全文 | 2919篇 |
免费 | 94篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 8篇 |
妇产科学 | 11篇 |
基础医学 | 205篇 |
口腔科学 | 4篇 |
临床医学 | 130篇 |
内科学 | 139篇 |
皮肤病学 | 1686篇 |
神经病学 | 8篇 |
特种医学 | 51篇 |
外科学 | 62篇 |
综合类 | 265篇 |
预防医学 | 70篇 |
眼科学 | 5篇 |
药学 | 201篇 |
1篇 | |
中国医学 | 175篇 |
肿瘤学 | 16篇 |
出版年
2024年 | 3篇 |
2023年 | 79篇 |
2022年 | 95篇 |
2021年 | 125篇 |
2020年 | 152篇 |
2019年 | 90篇 |
2018年 | 74篇 |
2017年 | 96篇 |
2016年 | 123篇 |
2015年 | 108篇 |
2014年 | 188篇 |
2013年 | 177篇 |
2012年 | 158篇 |
2011年 | 149篇 |
2010年 | 126篇 |
2009年 | 100篇 |
2008年 | 99篇 |
2007年 | 94篇 |
2006年 | 96篇 |
2005年 | 72篇 |
2004年 | 62篇 |
2003年 | 69篇 |
2002年 | 62篇 |
2001年 | 43篇 |
2000年 | 49篇 |
1999年 | 61篇 |
1998年 | 53篇 |
1997年 | 42篇 |
1996年 | 39篇 |
1995年 | 45篇 |
1994年 | 36篇 |
1993年 | 24篇 |
1992年 | 17篇 |
1991年 | 26篇 |
1990年 | 22篇 |
1989年 | 19篇 |
1988年 | 17篇 |
1987年 | 16篇 |
1986年 | 17篇 |
1985年 | 13篇 |
1984年 | 13篇 |
1983年 | 6篇 |
1982年 | 11篇 |
1981年 | 17篇 |
1980年 | 10篇 |
1979年 | 19篇 |
1978年 | 13篇 |
1977年 | 6篇 |
1975年 | 1篇 |
1972年 | 5篇 |
排序方式: 共有3038条查询结果,搜索用时 15 毫秒
1.
《Advances in medical sciences》2022,67(2):262-268
PurposeEpidermal hyperplasia and the involvement of immune cells characterize the clinical picture of psoriasis. Among the several factors involved, attention has been focused on sirtuin 1 (SIRT1) - a deacetylase endowed with a variety of functions including the control of metabolic and inflammatory processes-, and on nicotinamide phosphoribosyltransferase (NAMPT), important for SIRT1 activation and involved in inflammatory events. The aim of the study was to analyze changes of SIRT1 and NAMPT expression in psoriatic skin.Patients and methodsSamples from healthy controls and psoriatic patients were subjected to immunohistochemical analysis.ResultsA strong downregulation of SIRT1 expression was observed in skin samples from psoriatic patients compared to healthy controls. This was accompanied by a parallel reduction of adenosine monophosphate-activated kinase (AMPK) expression and, more strikingly, by the disappearance of cells immunolabeled for its active, phosphorylated form (pAMPK). In both cases, analysis of the distribution of immunopositive cells revealed a shift towards reduced intensity of staining. In contrast, NAMPT expression was upregulated in psoriatic samples in line with its pro-inflammatory role. This was again more visible with an intensity-based distribution analysis that evidenced a shift towards more intensely immunostained cell populations.ConclusionsThe present data correlate in the same samples the expression of SIRT1, pAMPK/AMPK and NAMPT in psoriasis and open the way for novel pharmacological targets in the treatment of the disease. 相似文献
2.
《Saudi Pharmaceutical Journal》2022,30(4):382-397
The transdermal permeation of curcumin aided by choline and geranic acid ionic liquid (CAGE-IL) was addressed as a potential treatment for skin diseases. An in-depth analysis of the effect of CAGE-IL concentration in the enhancement of transdermal permeation of curcumin was performed, and the results were modelled via nonlinear regression analysis. The results obtained showed that a low percentage of CAGE-IL (viz. 2.0%, w/w) was effective in disrupting the skin structure in a transient fashion, facilitating the passage of curcumin dissolved in it. 相似文献
3.
目的 探讨聚焦解决护理模式结合健康教育对银屑病患者心理状态、应对方式的影响。方法 选取2020年2月至2021年2月我院收治的100例银屑病患者,随机分为观察组(聚焦解决护理模式结合健康教育)与对照组(常规健康教育)。比较两组的心理状态及应对方式。结果 干预后,观察组的焦虑自评量表(SAS)、抑郁自评量表(SDS)评分低于对照组(P<0.05)。干预后,观察组的面对评分高于对照组,屈服、回避评分低于对照组(P<0.05)。干预后,观察组的病耻感评分低于对照组(P<0.05)。结论 聚焦解决护理模式结合健康教育可有效改善银屑病患者的不良情绪,减轻病耻感,转变疾病应对方式。 相似文献
4.
目的:探讨三黄消疕膏用于治疗寻常型银屑病血热证的临床效果和安全性。方法:选取2017年12月-2018年11月就诊于我院的寻常型银屑病患者80例,根据随机数字表法,分为治疗组和对照组,对照组口服决银颗粒治疗,治疗组除口服决银颗粒外,外用三黄消疕膏于局部皮损处,治疗2周后,分别对两组患者进行皮损面积及严重程度(Psoriasis Area and Severity Index,PASI)评分、皮肤病生活质量指数(Dermatology Life Quality Index,DLQI)评分、有效率、不良反应发生率评分。结果:治疗后,两组患者PASI评分下降,差异有统计学意义(t=3.34,P<0.05);DLQI评分下降,差异有统计学意义(t=5.59,P<0.05);治疗组有效率为91%,对照组有效率为62%,差异有统计学意义(χ^2=30.09,P<0.01);两组患者治疗后不良反应发生率较低,差异无统计学意义(P>0.05)。结论:三黄消疕膏联合决银颗粒治疗寻常型银屑病血热证可取得较好的临床效果,且安全性较高,值得推广。 相似文献
5.
Psoriasis is not only a chronic inflammatory skin disease but also a psychosomatic disorder. Depression is one of the most common associated diseases, which aggravates psoriatic skin lesions and affects the life quality of patients. Clinical experiments establish a correlation between psoriasis and depression; however, the mechanisms yet unclear because only a few related studies are available. Therefore, to investigate whether imiquimod-induced psoriasis-like mice showed depressive-like behavior, 5% imiquimod cream was smeared on the back of mice to induce psoriasis-like skin lesions for 8 days. Consequently, the psoriasis area and severity index (PASI) score, epidermal thickness, expression of Ki67 and CD3+ T lymphocyte, the content of IL-12p70, IL-17A, and IL-23 in skin lesions were increased. The psoriasis-like mice presented significant changes in body mass. The sugar water preference rate, the central area distance and area time, and the content of 3,4-dihydroxyphenylaceticacid (DOPAC) and noradrenaline (NE) in the prefrontal cortex, 5-hydroxytryptamine (5-HT), adrenaline (Ad), and DOPAC in the hippocampus, and Ad and γ-aminobutyric acid (GABA) in the hypothalamus of psoriasis-like mice were significantly decreased. The results showed that after the application of imiquimod, depressive-like behaviors appeared in psoriasis-like mice, and the secretion of related neurotransmitters was disordered. Thus, these mice could be used as animal models for studying psoriasis complicated with depression symptoms. 相似文献
6.
BackgroundThe efficacy and safety of etanercept in the treatment of psoriasis has been proven, and the drug was approved for the treatment of moderate to severe psoriasis. However, there have been few studies that have presented real-world data focused on concomitant treatment during etanercept treatment, and the switching pattern after discontinuation of etanercept.ObjectiveTo reveal the real-world treatment pattern of etanercept-based psoriasis treatment and to investigate the switching pattern after withdrawal of etanercept.MethodsWe enrolled 66 patients with psoriasis who were treated with etanercept. We collected data regarding the demographic characteristics of the patients, etanercept treatment schedules, and other treatments administered during the etanercept treatment period. We also investigated the treatment pattern after the discontinuation of etanercept with emphasis on the drug-free interval and the administered treatment modalities.ResultsThe mean treatment duration was 22.7±26.1 months and the mean number of etanercept injections was 21.5±27.9. Thirty-six patients were administered concomitant systemic medication or phototherapy. After discontinuation of etanercept, 54 patients were followed up and 34 of these patients were administered other systemic medication or phototherapy; phototherapy and cyclosporine was the most commonly administered treatment modality and 27.4% of treatments used biologics.ConclusionThe treatment schedule for etanercept was modified according to the severity of psoriasis and concomitant treatment was administered to improve the effectiveness of treatment in the patients enrolled in the study. We also found that most patients required other treatment modalities to control psoriasis during the period of etanercept treatment. 相似文献
7.
8.
《Reumatología clinica》2021,17(10):611-621
Psoriatic arthritis is a chronic systemic inflammatory disease that affects the skin, musculoskeletal structures and other organs and systems compromising functionality, quality of life and reducing the life expectancy of patients. It is a complex disease that requires specialist and timely care and management. The alternatives for treating the manifestations of psoriatic arthritis have increased and the effect of the different agents on specific manifestations has been clarified in recent studies. Therefore, we should incorporate the available evidence to build a strategy for the treatment of these patients. The Mexican College of Rheumatology selected a committee to evaluate these different alternatives and make recommendations.MethodsThe study group included 16 rheumatologists and 3 certified dermatologists, selected from different health institutions and regions of the country. An executive committee was formed to coordinate the meetings and a committee of experts selected the literature search criteria, prepared the research questions, rated the quality of the evidence, and produced the recommendations in the different disease domains based on the GRADE methodology.Results24 updated recommendations were generated for the treatment of patients with psoriatic arthritis. The recommendations establish the role of the drugs currently available in our country. The importance of adequate disease control is emphasized, individualizing the level of involvement of each patient in each of the six domains potentially affected by the disease. In addition, the sequence in the choice of treatments available for each domain is established, based on their efficacy, safety profile and accessibility.ConclusionsWith this consensus document, it will be possible to improve the care of patients with psoriatic arthritis. The recommendations were generated based on the best available information and in consideration of the Mexican health system. 相似文献
9.
10.